NW
NVAX icon

NewEdge Wealth’s Novavax NVAX Stock Holding History

NewEdge Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Sell
130,000
-239
-0.2% -$2.17K 0.01% 610
2025
Q4 		$875K Sell
130,239
-39,761
-23% -$300K 0.01% 671
2025
Q3 		$1.31M Sell
170,000
-4,750
-3% -$37K 0.02% 499
2025
Q2 		$1.53M Sell
174,750
-5,255
-3% -$34.8K 0.02% 435
2025
Q1 		$1.15M Buy
180,005
+9,888
+6% +$81.7K 0.02% 446
2024
Q4 		$1.37M Buy
170,117
+70,117
+70% +$676K 0.02% 429
2024
Q3 		$1.26M Hold
100,000
– – 0.02% 430
2024
Q2 		$1.27M Buy
+100,000
New +$1.01M 0.03% 382

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NewEdge Wealth's NVAX Position: Q1 2026 in Review

NewEdge Wealth reduced its Novavax (NVAX) stake by 0.18% in Q1 2026, selling an estimated $2.17K and leaving 130,000 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #610.

NewEdge Wealth first reported a position in NVAX in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.53M in Q2 2025. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • NewEdge Wealth held 130,000 shares of Novavax worth $1.06M as of Q1 2026.
  • NewEdge Wealth sold 239 Novavax shares in Q1 2026, an estimated $2.17K.
  • Novavax made up 0.01% of NewEdge Wealth's portfolio in Q1 2026, its #610 holding.
  • NewEdge Wealth first reported a position in Novavax in Q2 2024 and has held it in 8 quarters since.
  • NewEdge Wealth's Novavax position peaked at $1.53M in Q2 2025.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on NewEdge Wealth's 13F filing for Q1 2026, filed 13 May 2026.